These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17848936)

  • 21. Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults.
    Kullmann S; Heni M; Veit R; Scheffler K; Machann J; Häring HU; Fritsche A; Preissl H
    Diabetes Care; 2015 Jun; 38(6):1044-50. PubMed ID: 25795413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diazoxide-mediated insulin suppression in obese men: a dose-response study.
    Schreuder T; Karreman M; Rennings A; Ruinemans-Koerts J; Jansen M; de Boer H
    Diabetes Obes Metab; 2005 May; 7(3):239-45. PubMed ID: 15811140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal insulin improves memory in humans.
    Benedict C; Hallschmid M; Hatke A; Schultes B; Fehm HL; Born J; Kern W
    Psychoneuroendocrinology; 2004 Nov; 29(10):1326-34. PubMed ID: 15288712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress.
    Bohringer A; Schwabe L; Richter S; Schachinger H
    Psychoneuroendocrinology; 2008 Nov; 33(10):1394-400. PubMed ID: 18804330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal insulin reduces olfactory sensitivity in normosmic humans.
    Brünner YF; Benedict C; Freiherr J
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1626-30. PubMed ID: 23928664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men.
    Ritze Y; Kern W; Ebner EM; Jahn S; Benedict C; Hallschmid M
    Front Endocrinol (Lausanne); 2018; 9():663. PubMed ID: 30524368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overweight humans are resistant to the weight-reducing effects of melanocortin4-10.
    Hallschmid M; Smolnik R; McGregor G; Born J; Fehm HL
    J Clin Endocrinol Metab; 2006 Feb; 91(2):522-5. PubMed ID: 16317061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal insulin.
    Hallschmid M
    J Neuroendocrinol; 2021 Apr; 33(4):e12934. PubMed ID: 33506526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin modulates food-related activity in the central nervous system.
    Guthoff M; Grichisch Y; Canova C; Tschritter O; Veit R; Hallschmid M; Häring HU; Preissl H; Hennige AM; Fritsche A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):748-55. PubMed ID: 19996309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Awake, long-term intranasal insulin treatment does not affect object memory, odor discrimination, or reversal learning in mice.
    Bell GA; Fadool DA
    Physiol Behav; 2017 May; 174():104-113. PubMed ID: 28259806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administration.
    Hallschmid M; Benedict C; Born J; Kern W
    Expert Opin Drug Deliv; 2007 Jul; 4(4):319-22. PubMed ID: 17683246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes.
    Novak V; Milberg W; Hao Y; Munshi M; Novak P; Galica A; Manor B; Roberson P; Craft S; Abduljalil A
    Diabetes Care; 2014; 37(3):751-9. PubMed ID: 24101698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal Insulin for Alzheimer's Disease.
    Hallschmid M
    CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural correlates of olfactory and visual memory performance in 3D-simulated mazes after intranasal insulin application.
    Brünner YF; Rodriguez-Raecke R; Mutic S; Benedict C; Freiherr J
    Neurobiol Learn Mem; 2016 Oct; 134 Pt B():256-63. PubMed ID: 27492601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging.
    Maimaiti S; Anderson KL; DeMoll C; Brewer LD; Rauh BA; Gant JC; Blalock EM; Porter NM; Thibault O
    J Gerontol A Biol Sci Med Sci; 2016 Jan; 71(1):30-9. PubMed ID: 25659889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system effects of intranasally administered insulin during euglycemia in men.
    Kern W; Born J; Schreiber H; Fehm HL
    Diabetes; 1999 Mar; 48(3):557-63. PubMed ID: 10078556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-Dependent Effects of Intranasal Insulin on Resting-State Brain Activity.
    Kullmann S; Veit R; Peter A; Pohmann R; Scheffler K; Häring HU; Fritsche A; Preissl H; Heni M
    J Clin Endocrinol Metab; 2018 Jan; 103(1):253-262. PubMed ID: 29095982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes and clinical implications of intranasal insulin administration to the central nervous system.
    Santiago JCP; Hallschmid M
    Exp Neurol; 2019 Jul; 317():180-190. PubMed ID: 30885653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.